The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology ...

The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast ...

In a major medical breakthrough for Rajasthan, doctors at Eternal Hospital, Jaipur, have successfully replaced the tricuspid ...

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of ...

Foldax® Inc., a leader in heart valve innovation, today announced that the Indian Central Drugs Standard Control Organization (CDSCO) approved its TRIA™ Mitral Valve. Dolphin Life Science India LLP ...

Women are less likely than men to be given treatment for a potentially fatal heart condition, according to a new analysis.

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is ...

Edwards Lifesciences, a leader in heart medical devices, has shown strong growth, innovation, and attractive valuation. Read ...

In a first for Nagpur, a remarkable milestone in cardiac care was achieved as three transcatheter aortic valve implantation ...

The research showed that after a diagnosis of aortic stenosis, women are 11% less likely to be referred on to secondary care ...